SOURCE: PURE Bioscience, Inc

PURE Bioscience, Inc

November 12, 2014 08:36 ET

PURE Bioscience Updates Ongoing Sales Path for EPA Approved PURE® Hard Surface Disinfectant With SUBWAY® Restaurants and Others

SAN DIEGO, CA--(Marketwired - Nov 12, 2014) - PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today provided an update on its sales path to commercialize PURE® Hard Surface as a superior disinfectant for food contact surfaces in restaurant chains and food processors/manufacturers.

Despite the recently announced delay in the FDA approval process to commercialize SDC as a direct food contact poultry processing aid, PURE remains laser focused on its core, primary strategy to commercialize SDC disinfectant for food contact surfaces in restaurants and food processors. The Company's sales strategy for PURE Hard Surface is in no way affected by the circumstances surrounding its withdrawal of its Food Contact Notification (FCN) submission to the FDA for poultry.

Hank R. Lambert, CEO of PURE, said that, "We are confidently moving forward with execution of commercialization of PURE Hard Surface into SUBWAY®, other restaurant chains and food processors.

"As discussed on Monday, we were taken by surprise and disappointed to withdraw our FCN application with the FDA for poultry processing. As we wait for further information and direction from the FDA, we continue to aggressively execute our PURE Hard Surface disinfectant sales plan. We are focused on our sales roll out to the SUBWAY® chain and developing and expanding additional distribution channels and applications. Our confidence in SDC remains unshaken," Lambert concluded.

As previously announced, the efficacy and environmental friendliness of PURE Hard Surface have been validated by SUBWAY® Restaurants*, and the product has recently been approved for use in SUBWAY®'s nearly 27,000 franchised stores in the US.

Collaborating with SUBWAY®, PURE has developed marketing materials and a sales rollout plan, which the Company began executing this week. Working through SUBWAY®'s Development Agents, PURE Hard Surface is being presented at a series of meetings of large franchisee groups -- beginning this week covering Southern California. The very positive feedback received from franchisees which began using PURE Hard Surface during this summer's 650-store test, and have continued using the product in their stores, is being highlighted.

The Company is also in active discussions with SUBWAY® for expanded use and additional applications of PURE Hard Surface within the stores.

PURE continues outreach to additional restaurant chains. As a result of progress with SUBWAY®, we are in discussions to develop testing protocols with several chains. Also, given the increased industry concern about and focus on Norovirus, the Company is in discussions with restaurant chains who are specifically interested in testing PURE Hard Surface's superior efficacy in killing that virus.

PURE is developing a new distribution channel for food processing using SDC in food contact surface disinfection. The Company has received initial orders by working with contract cleaning and sanitizing companies whose clients are food processing companies. PURE is in discussions with additional similar companies to broaden and deepen its reach into food processors, positioning SDC as part of a uniquely powerful preventative sanitation program.

The Company expects this new channel will prove to be a means to broaden its sales efforts and increase the number of food processors using its products on a regular basis. PURE has successfully demonstrated impressively superior speed and level of pathogen kill to several companies. SDC's superior results, against Listeria in particular, is what these companies find extremely valuable.

About PURE Bioscience, Inc.
PURE Bioscience, Inc. is focused on developing and commercializing our proprietary antimicrobial products primarily in the food safety arena -- providing solutions to the health and environmental challenges of pathogen and hygienic control. Our technology platform is based on patented stabilized ionic silver, and our initial products contain silver dihydrogen citrate, or SDC. SDC is a broad-spectrum, non-toxic antimicrobial agent, which offers 24-hour residual protection and formulates well with other compounds. As a platform technology, SDC is distinguished from existing products in the marketplace because of its superior efficacy, reduced toxicity and the inability of bacteria to form a resistance to it. PURE is headquartered in El Cajon, California (San Diego metropolitan area). Additional information on PURE is available at

Forward-looking Statements
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause our actual results to differ materially from the forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, the Company's cash position and liquidity requirements; the Company's failure to implement or otherwise achieve the benefits of its proposed business initiatives and plans; acceptance of the Company's current and future products and services in the marketplace, including acceptance of the Company's PURE® Hard Surface disinfectant by SUBWAY® franchisees; the ability of the Company to develop effective new products and receive regulatory approvals of such products; competitive factors; dependence upon third-party vendors, including to manufacture its products; and other risks detailed in the Company's periodic report filings with the Securities and Exchange Commission, including our annual report on Form 10-K filed October 28, 2014. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release.

* SUBWAY® is a registered trademark of Doctor's Associates Inc. 

Contact Information

  • Contacts:
    Peter C. Wulff
    CFO & COO
    PURE Bioscience, Inc.
    619-596-8600 ext.111
    Email Contact

    Terri MacInnis
    VP of IR
    Bibicoff + MacInnis, Inc.
    Email Contact

    Tom Hemingway
    Redwood Investment Group
    Email Contact